Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Bioinformatics (Oxford, England)|May 13, 2022
Integrative analysis of relative abundance data and presence-absence data of the microbiome using the LDMZhengyi Zhu, Glen A Satten, Yi-Juan Hu
Microbiome|June 10, 2021
Constraining PERMANOVA and LDM to within-set comparisons by projection improves the efficiency of analyses of matched sets of microbiome dataZhengyi Zhu, Glen A Satten, Caroline Mitchell, et al.
Dalton Transactions (Cambridge, England : 2003)|July 14, 2021
Enhancing the thermoelectric properties of SnTe <i>via</i> introducing PbTe@C core-shell nanostructuresJingwen Zhang, Song Li, Zhengyi Zhu, et al.
Smart Medicine|August 27, 2024
Roles of N6-methyladenosine epitranscriptome in non-alcoholic fatty liver disease and hepatocellular carcinomaYuyan Chen, Zhengyi Zhu, Lu Zhang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 3, 2025
MSCs Suppress Macrophage Necroptosis and Foster Liver Regeneration by Modulating SP1/SK1 Axis in Treating Acute Severe Autoimmune HepatitisRan An, Zhengyi Zhu, Yuyan Chen, et al.
Smart Medicine|August 27, 2024
Multidimensional landscape of non-alcoholic fatty liver disease-related disease spectrum uncovered by big omics data: Profiling evidence and new perspectivesZhengyi Zhu, Yuyan Chen, Xueqian Qin, et al.
Cell Death Discovery|January 19, 2024
CHEK2 knockout is a therapeutic target for TP53-mutated hepatocellular carcinomaYuyan Chen, Zhengyi Zhu, Xingyu Wu, et al.
International Journal of Biological Macromolecules|May 13, 2026
A high-toughness, high-strength, and highly sensitive nanocellulose-based double-network eutectogel with environmental stability for a multifunction sensorShiyu Fan, Jiayi Ma, Zhengyi Zhu, et al.
Environmental Science & Technology|July 2, 2026
Ecotype-Specific Drilosphere Microbiome Reprogramming Influencing Microplastic Impacts on Soil Carbon-Nitrogen Characteristics and Earthworm HealthLei Wang, Hao Qiu, Hongyan Ma, et al.
BMJ Open|February 14, 2020
Cost-effectiveness analysis of cetuximab combined with chemotherapy as a first-line treatment for patients with RAS wild-type metastatic colorectal cancer based on the TAILOR trialHuijuan Wang, Lingfei Huang, Peng Gao, et al.
Pageof 4